Avanir Targets Wockhardt In Nuedexta Patent Blitz
Avanir claims that Mumbai, India-based Wockhardt's planned version of the drug, which treats involuntary laughing and crying disorders in patients with underlying brain conditions, infringes two of its patents.
The lawsuit broadens Avanir's fight to retain control of the drug's manufacture. Earlier in August, it sued two...
To view the full article, register now.